Seeding and scaling Ontario’s premiere entrepreneurial ventures for patients and the economy.
Increasing the value of Ontario’s best oncology innovations and attracting investment from the private sector.
In total funding and equity investments
In additional financing attracted
Ontario start-ups created
Our investments are at the forefront of Ontario’s biotech ecosystem.
Our investments bridge the life sciences seed funding gap.
Our investments have resulted in significant partnerships, clinical trials, job creation and leveraged financing for the province.
Keep up to date on our investments and business developments in recent news stories and summaries.
We were established by the Ontario Institute for Cancer Research (OICR) to support commercialization, technology transfer, and development activities. OICR conducts and enables world-class cancer research, filling a critical role as a pan-provincial connector of oncology researchers, resources and cancer innovation development. Together with OICR, we drive a shared vision to attract more R&D investment in Ontario and help the best oncology innovations reach the market and save lives.
FACIT is funded in part by the Government of Ontario through OICR